The latest findings from the largest European project monitoring illicit drug use through wastewater analysis are released today in Wastewater analysis and drugs — a European multi-city study, published by the Europe-wide SCORE group, in association with the European Union Drugs Agency (EUDA). This year’s findings highlight a marked decline in MDMA residues across the participating cities, alongside strong increases in ketamine and cocaine detections.
The project analysed wastewater in 115 European cities from 25 countries (23 EU, Norway + Türkiye) to explore the drug-taking behaviours of…
Čtěte více
Ketamine produced legitimately outside the EU to make medicines is increasingly finding its way onto Europe’s illicit drug market, according to a new report published today by the EU Drugs Agency (EUDA). The study, Ketamine in Europe, provides the first comprehensive multi-country intelligence picture of how organised criminal networks are exploiting legitimate pharmaceutical supply chains in Europe and the implications this may have for public health and law enforcement. The report was produced within the framework of the European Multidisciplinary Platform Against Criminal Threats (EMPACT…
Čtěte více
Why is it important to consider a gender perspective in the drugs field? What do the data tell us about the main gender differences in drug use and drug-related harms in Europe? Is the gender gap in drug use narrowing among younger generations? How can gender-responsive interventions be implemented in the drugs field?
These are just some of the questions posed in our Frequently asked questions (FAQ): gender and drugs in Europe published today.
The new resource provides answers to important questions on gender and drugs, with a particular focus on the European situation…
Čtěte více
